Icometrix Gets First CPT III Code Issued by AMA for AI Brain MRI Software
Reportedly receiving the first Current Procedural Terminology (CPT) III code from the American Medical Association (AMA) for artificial intelligence (AI)-enabled brain magnetic resonance imaging (MRI) software, Icometrix says its adjunctive quantification software can be utilized for diagnosis and assessment of conditions ranging from Alzheimer’s disease and epilepsy to stroke and dementia.
Creating a potential path for reimbursement, the American Medical Association (AMA) has issued a Current Procedural Terminology (CPT) III code for the use of icometrix’s artificial intelligence (AI)-powered brain magnetic resonance imaging (MRI) quantification software.
Icometrix, which has five Food and Drug Administration (FDA)-cleared AI software applications for brain MRI and computed tomography (CT), said the CPT III code is the first one issued for adjunctive AI quantification of brain MRI scans.
“Precision medicine is vital for improving treatment of neurological conditions, and especially for multiple sclerosis,” noted Tim Coetzee, PhD, the chief advocacy, services, and science officer at the National Multiple Sclerosis Society. “This recognition creates a path for icometrix’s innovative technology to be integrated into the management of multiple sclerosis (MS) and takes us one step closer to a future where precision medicine guides treatment decisions.”
Icobrain ms, one of the aforementioned AI software applications, facilitates objective quantification and tracking of white matter hyperintensities on FLAIR, TI MRI and contrast-enhanced T1 MRI, according to icometrix. The company added that its portfolio of AI-enabled neuroimaging software can be utilized in the diagnosis and assessment of treatment for conditions ranging from Alzheimer’s disease and MS to stroke and epilepsy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
